missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Alivin 1 Monoclonal Antibody (290728)
Rat Monoclonal Antibody
Marke: Invitrogen™ MA561148
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
Reconstitute at 0.5 mg/mL in sterile PBS.
A novel primary response gene, Alivin 1 (ali1), is an activity-dependent gene and promotes survival of neurons. Sequence analyses reveal that rat, mouse, and human Ali1 proteins contain seven leucine-rich repeats, one IgC2-like loop and a transmembrane domain, and display homology to Kek and Trk families. Results suggest that expression of ali1 promotes depolarization-dependent survival of the granule neuron. Mouse ali1 was mapped to a locus approximately 55.3 cM from the centromere on chromosome 15 that is syntenic to positional candidate loci for familial Alzheimer's disease type 5 and Parkinson's disease 8 on human chromosome 12.
Spezifikation
| Alivin 1 | |
| Monoclonal | |
| 0.5 mg/mL | |
| PBS with trehalose and no preservative | |
| Q80ZD9, Q86SJ2 | |
| Amigo2 | |
| Mouse myeloma cell line NS0-derived recombinant mouse AMIGO2, Met39-Ala391. | |
| 100 μg | |
| Primary | |
| Human, Mouse | |
| Antibody | |
| IgG2a |
| Western Blot | |
| 290728 | |
| Unconjugated | |
| Amigo2 | |
| adhesion molecule with Ig like domain 2; adhesion molecule with Ig-like domain 2; AI415330; Ali1; alivin 1; alivin-1; amigo2; AMIGO-2; amigo2 {ECO:0000312; amphoterin induced gene 2; amphoterin induced gene and ORF 2; amphoterin-induced protein 2; AW208913; DEGA; differentially expressed in gastric adenocarcinoma; differentially expressed in gastric adenocarcinomas; EMBL:AAO48951.1}; transmembrane protein AMIGO2 | |
| Rat | |
| Protein A/G | |
| RUO | |
| 105827, 347902 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Lyophilized |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur